Insider

Stuart A Arbuckle Insider Trading Activity

Every SEC Form 4 transaction reported by Stuart A Arbuckle, sourced directly from SEC EDGAR and updated as new filings are accepted.

Latest filing:

Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.

Quick Answer

Is Stuart A Arbuckle buying or selling?

Stuart A Arbuckle reported 0 open-market buys ($0) and 65 sells ($70.9M) across 65 Form 4 filings at 1 company — a net selling position of $70.9M.

Source: SEC EDGAR Form 4

What stands out

  • All 65 of Stuart A Arbuckle's Form 4 filings are for one company, VERTEX PHARMACEUTICALS INC / MA (VRTX).
  • The most recent Form 4 was accepted on May 17, 2024 (2 years ago).
  • No open-market purchases or sales were reported in the last 12 months.

Key Statistics (as of May 17, 2024)

Total Form 4 filings
65
SEC EDGAR
Companies
1
Buys (0)
$0
Sells (65)
$70.9M

Insider sentiment

Net selling

Net insider flow of $70.9M in net selling, filed between Jan 12, 2018 – May 17, 2024.

Companies Stuart A Arbuckle files for

#CompanyForm 4 filings
1VRTXVERTEX PHARMACEUTICALS INC / MA65

Recent Stuart A Arbuckle transactions

DateTickerRoleTypeSharesValueFiling
May 17, 2024VRTXEVP, COOSale69$29.7KSEC ↗
Feb 27, 2024VRTXEVP, COOSale5.0K$2.1MSEC ↗
Feb 23, 2024VRTXEVP, COOSale3.6K$1.5MSEC ↗
Feb 21, 2024VRTXEVP, COOSale4.8K$2.0MSEC ↗
Feb 13, 2024VRTXEVP, COOSale4.3K$1.8MSEC ↗
Dec 15, 2023VRTXEVP, COOSale8.6K$3.4MSEC ↗
Jun 20, 2023VRTXEVP, COOSale8.6K$3.0MSEC ↗
Jun 1, 2023VRTXEVP, COOSale82$27.0KSEC ↗
Feb 28, 2023VRTXEVP, COOSale5.0K$1.4MSEC ↗
Feb 24, 2023VRTXEVP, COOSale2.4K$706.7KSEC ↗
Feb 22, 2023VRTXEVP, COOSale2.4K$705.6KSEC ↗
Feb 16, 2023VRTXEVP, COOSale6.4K$1.9MSEC ↗
Feb 14, 2023VRTXEVP, COOSale4.9K$1.5MSEC ↗
Aug 17, 2022VRTXEVP, COOSale22.2K$6.7MSEC ↗
Aug 12, 2022VRTXEVP, COOSale180$54.1KSEC ↗
Aug 10, 2022VRTXEVP, COOSale5.7K$1.7MSEC ↗
May 18, 2022VRTXEVP, COOSale133$33.4KSEC ↗
May 4, 2022VRTXEVP, COOSale306$80.8KSEC ↗
Nov 16, 2021VRTXEVP, COOSale3$561.78SEC ↗
May 19, 2021VRTXEVP, Chief Comm & Ops OfficerSale109$23.6KSEC ↗
Feb 26, 2021VRTXEVP, Chief Commercial OfficerSale3.6K$776.0KSEC ↗
Feb 19, 2021VRTXEVP, Chief Commercial OfficerSale7.8K$1.7MSEC ↗
Feb 16, 2021VRTXEVP, Chief Commercial OfficerSale5.2K$1.1MSEC ↗
Feb 5, 2021VRTXEVP, Chief Commercial OfficerSale1.6K$332.1KSEC ↗
Nov 18, 2020VRTXEVP, Chief Commercial OfficerSale7$1.6KSEC ↗

Showing the 25 most recent filings of 65. Screen every filing.

Stuart A Arbuckle insider trading FAQ

Is Stuart A Arbuckle buying or selling?

Across 65 SEC Form 4 filings, Stuart A Arbuckle reported 0 open-market purchases totaling $0 and 65 sales totaling $70.9M — a net selling position of $70.9M.

Which companies does Stuart A Arbuckle file Form 4s for?

Stuart A Arbuckle has reported insider transactions at 1 company, most often VERTEX PHARMACEUTICALS INC / MA (VRTX).

How far back does Stuart A Arbuckle's filing history go?

Trabud holds Stuart A Arbuckle's SEC Form 4 filings from Jan 12, 2018 – May 17, 2024, sourced directly from SEC EDGAR.

Where does Trabud get Stuart A Arbuckle's insider trading data?

Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.

Related Content

Track Stuart A Arbuckle and every other insider

Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.

Open the screener